Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Blood Cancer Journal
|
March 8, 2020
Bright PD-1 expression by flow cytometry is a powerful tool for diagnosis and monitoring of angioimmunoblastic T-cell lymphoma
Mariko Yabe, Qi Gao, Neval Ozkaya, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 2, 2017
The histopathology of Erdheim-Chester disease: a comprehensive review of a molecularly characterized cohort
Neval Ozkaya, Marc K Rosenblum, Benjamin H Durham, et al.
The American Journal of Surgical Pathology
|
March 19, 2021
Localized Peritumoral AL Amyloidosis Associated With Mantle Cell Lymphoma With Plasmacytic Differentiation
Mariko Yabe, Neval Ozkaya, Daphne de Jong, et al.
Haematologica
|
February 24, 2018
Single-agent dabrafenib for <i>BRAF</i><sup>V600E</sup>-mutated histiocytosis
Ankush Bhatia, Gary Ulaner, Raajit Rampal, et al.
Annals of Clinical and Translational Neurology
|
April 1, 2020
Neurological manifestations of Erdheim-Chester Disease
Louisa C Boyd, Kevin J O'Brien, Neval Ozkaya, et al.
Nature
|
August 31, 2017
A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease
Elvira Mass, Christian E Jacome-Galarza, Thomas Blank, et al.
Blood
|
November 2, 2022
A RUNX1-FPDMM rhesus macaque model reproduces the human phenotype and predicts challenges to curative gene therapies
Byung-Chul Lee, Yifan Zhou, Erica Bresciani, et al.
Neuro-Oncology
|
January 18, 2020
Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient series
Ankush Bhatia, Vaios Hatzoglou, Gary Ulaner, et al.
Haematologica
|
May 25, 2019
Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by <i>MAP2K1</i>
Jérôme Razanamahery, Eli L Diamond, Fleur Cohen-Aubart, et al.
Blood Advances
|
May 23, 2020
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms
Natasha E Lewis, Kseniya Petrova-Drus, Sarah Huet, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Blood Cancer Journal
|
March 8, 2020
Bright PD-1 expression by flow cytometry is a powerful tool for diagnosis and monitoring of angioimmunoblastic T-cell lymphoma
Mariko Yabe, Qi Gao, Neval Ozkaya, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 2, 2017
The histopathology of Erdheim-Chester disease: a comprehensive review of a molecularly characterized cohort
Neval Ozkaya, Marc K Rosenblum, Benjamin H Durham, et al.
The American Journal of Surgical Pathology
|
March 19, 2021
Localized Peritumoral AL Amyloidosis Associated With Mantle Cell Lymphoma With Plasmacytic Differentiation
Mariko Yabe, Neval Ozkaya, Daphne de Jong, et al.
Haematologica
|
February 24, 2018
Single-agent dabrafenib for <i>BRAF</i><sup>V600E</sup>-mutated histiocytosis
Ankush Bhatia, Gary Ulaner, Raajit Rampal, et al.
Annals of Clinical and Translational Neurology
|
April 1, 2020
Neurological manifestations of Erdheim-Chester Disease
Louisa C Boyd, Kevin J O'Brien, Neval Ozkaya, et al.
Nature
|
August 31, 2017
A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease
Elvira Mass, Christian E Jacome-Galarza, Thomas Blank, et al.
Blood
|
November 2, 2022
A RUNX1-FPDMM rhesus macaque model reproduces the human phenotype and predicts challenges to curative gene therapies
Byung-Chul Lee, Yifan Zhou, Erica Bresciani, et al.
Neuro-Oncology
|
January 18, 2020
Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient series
Ankush Bhatia, Vaios Hatzoglou, Gary Ulaner, et al.
Haematologica
|
May 25, 2019
Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by <i>MAP2K1</i>
Jérôme Razanamahery, Eli L Diamond, Fleur Cohen-Aubart, et al.
Blood Advances
|
May 23, 2020
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms
Natasha E Lewis, Kseniya Petrova-Drus, Sarah Huet, et al.
Page
of 3